176 related articles for article (PubMed ID: 24593233)
1. Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma.
de Waal AC; van Harten-Gerritsen AS; Aben KK; Kiemeney LA; van Rossum MM; Blokx WA
Br J Dermatol; 2014 Apr; 170(4):874-7. PubMed ID: 24593233
[TBL] [Abstract][Full Text] [Related]
2. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
[TBL] [Abstract][Full Text] [Related]
3. Implementation of the 7th edition AJCC staging system: Effects on staging and survival for pT1 melanoma. A Dutch population based study.
Oude Ophuis CM; Louwman MW; Grünhagen DJ; Verhoef K; van Akkooi AC
Int J Cancer; 2017 Apr; 140(8):1802-1808. PubMed ID: 28109000
[TBL] [Abstract][Full Text] [Related]
4. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
[TBL] [Abstract][Full Text] [Related]
5. Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients.
Ponti G; Pollio A; Cesinaro AM; Pellacani G; Magnoni C; Seidenari S
Cancer Epidemiol; 2012 Jun; 36(3):303-5. PubMed ID: 22153914
[TBL] [Abstract][Full Text] [Related]
6. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
7. [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?].
Bösmüller H; Haitchi-Petnehazy S; Hintringer T; Mentzel T
Pathologe; 2012 Mar; 33(2):113-7. PubMed ID: 21845361
[TBL] [Abstract][Full Text] [Related]
8. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.
Mitteldorf C; Bertsch HP; Jung K; Thoms KM; Schön MP; Tronnier M; Kretschmer L
Ann Surg Oncol; 2014 Jul; 21(7):2252-8. PubMed ID: 24652352
[TBL] [Abstract][Full Text] [Related]
10. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
11. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual.
Isom C; Wheless L; Hooks MA; Kauffmann RM
JAMA Dermatol; 2019 May; 155(5):572-577. PubMed ID: 30840034
[TBL] [Abstract][Full Text] [Related]
12. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas.
Fidanzi C; Bevilacqua M; D'Erme AM; Morganti R; Viacava P; Manzo Margiotta F; Romanelli M; Dini V; Janowska A; Bagnoni G
J Plast Reconstr Aesthet Surg; 2023 Aug; 83():215-220. PubMed ID: 37279633
[TBL] [Abstract][Full Text] [Related]
13. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node.
Mori M; Sugiura M; Kono M; Matsumoto T; Sawada M; Yokota K; Yasue S; Shibata S; Sakakibara A; Nakamura S; Tomita Y; Akiyama M
J Cutan Pathol; 2013 Dec; 40(12):1027-34. PubMed ID: 24111935
[TBL] [Abstract][Full Text] [Related]
15. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
16. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.
Litzner BR; Etufugh CN; Stepenaskie S; Hynan LS; Cockerell CJ
Am J Dermatopathol; 2012 Dec; 34(8):827-32. PubMed ID: 22878366
[TBL] [Abstract][Full Text] [Related]
17. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?
Kirkland EB; Zitelli JA
Dermatol Surg; 2014 Sep; 40(9):937-45. PubMed ID: 25072127
[TBL] [Abstract][Full Text] [Related]
18. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
Chu VH; Tetzlaff MT; Torres-Cabala CA; Prieto VG; Bassett R; Gershenwald JE; McLemore MS; Ivan D; Wang WL; Ross MI; Curry JL
Biomed Res Int; 2013; 2013():898719. PubMed ID: 24369020
[TBL] [Abstract][Full Text] [Related]
19. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
Nading MA; Balch CM; Sober AJ
Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007
[TBL] [Abstract][Full Text] [Related]
20. Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.
Eriksson H; Frohm-Nilsson M; Hedblad MA; Hellborg H; Kanter-Lewensohn L; Krawiec K; Lundh Rozell B; Månsson-Brahme E; Hansson J
Acta Derm Venereol; 2013 Jul; 93(4):411-6. PubMed ID: 23306667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
